A diagnosis of advanced systemic mastocytosis (advSM), a rare blood disorder in which too many mast cells accumulate in various parts of the body, can cause a range of strong emotions. AdvSM ...

Systemic mastocytosis is a rare blood disorder in which too many mast cells accumulate in various parts of the body. Advanced forms of systemic mastocytosis have more significant symptoms and in ...

Indolent systemic mastocytosis (ISM) is one of the five subtypes of systemic mastocytosis, a condition characterized by the ...

The DALY scores of disease burden were commensurate with many serious disorders, including lymphoma and leukemia, data that support referral of patients with mastocytosis to specialist centers.

NICE has recommended broad use of Blueprint Medicines' recently-approved therapy for rare blood disorder advanced systemic mastocytosis (ASM) by the NHS in England and Wales, including first-line ...

Mastocytosis is characterized by focal accumulations of clonal mast cells in the skin and/or in internal organs such as bone marrow, spleen, lymph nodes or the gastrointestinal tract. In this ...

Blueprint Medicines Corporation (Nasdaq: BPMC) today reported financial results, provided a business update for the first ...

Mastocytosis is characterized by focal accumulations of clonal mast cells in the skin and/or in internal organs such as bone marrow, spleen, lymph nodes or the gastrointestinal tract. In this ...

"The expanded SUMMIT data presented at AAAAI 2025 reinforce our belief that bezuclastinib can rapidly and meaningfully improve a wide variety of symptoms that impact the daily lives of patients with ...

Systemic mastocytosis (SM) is a rare blood disorder in which the body produces too many mast cells. Part of the immune response, mast cells are a type of white blood cell that releases histamine ...